DOJ Keeps Self-Reporting Paperwork: No New Hassles, Just More Forms
Published Date: 5/1/2025
Notice
Summary
The Department of Justice wants to keep collecting info from people who report certain activities themselves. They’re asking for permission to continue this process, making sure it’s easy and clear. If you’re involved, keep an eye out for updates—this helps the DOJ stay on top of important info without wasting your time or money.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-15458, Civil Money Penalty for Actions in Contempt of an Immigration Judge's Proper Exercise of Authority
This notice of proposed rulemaking ("NPRM") would implement a provision of the Immigration and Nationality Act ("INA" or "the Act") that authorizes Immigration Judges, under regulations prescribed by the Attorney General, to sanction by civil money penalty any action (or inaction) in contempt of the proper exercise of their authority by certain individuals. The rule would: define the scope of the contempt authority; provide procedures for contempt findings, penalty determinations, and penalty payment; establish an appellate process; and implement oversight of the use of contempt authority. The rule would also make conforming changes to the grounds for practitioner discipline.
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160, Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-16775, Notice of Lodging of Proposed Consent Decree Under the Clean Water Act
2026-16606, Regulatory Agenda
The Department of Justice is publishing its 2026 Unified Agenda regulatory agenda pursuant to Executive Order 12866, "Regulatory Planning and Review," 58 FR 51735, and the Regulatory Flexibility Act, 5 U.S.C. 601 to 612 (1988).
Previous / Next Documents
Previous: 2025-07555, Open Meeting of the Taxpayer Advocacy Panel's Notices and Correspondence Project Committee
The Taxpayer Advocacy Panel's Notices and Correspondence Project Committee is holding a fun, open meeting by phone to hear your ideas on making IRS customer service better. If you’re a taxpayer, this is your chance to speak up and help improve how the IRS talks to you. No money changes now, but your feedback could shape future IRS updates!
Next: 2025-07557, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Obtaining Information To Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities
The FDA wants to learn more about the challenges and opportunities faced by compounding outsourcing facilities—places that make special medicines. They’ve asked the Office of Management and Budget to review their plan to collect this info, which helps improve safety and quality. This won’t cost businesses extra money but will ask for some helpful feedback soon.